Umberto Cillo is an expert in Surgery at Azienda Ospedaliera di Padova (Italy). As of October 2026, ScienceLeadR ranks Umberto Cillo in the top 1% of experts worldwide for Liver Transplantation, Tissue Transplantation and Liver Neoplasms. Umberto Cillo has authored 996 publications, the most recent in 2026, and is an investigator in 26 clinical trials, 6 of them ongoing. SLR score: 3,230 (community average: 125). How the SLR is computed.

LeadR Profile

3 230 ScienceLeadR Reputation 3230
Network Map

Surgery

Subspecialties: Hepatology - Transplantation - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Prof Umberto Cillo, MD, FEBS

Professor of General Surgery

Head, Department of Surgical Oncologic and Gastroenterologic Sciences, Padova University

Head, Department of Hepatology Padova University-Hospital

Director, General Surgery 2 – Hepato-Biliary-Pancreatic Surgery and Liver Transplant Center

University of Padova, Padova - Italy



  1. Full Professor of General Surgery at University of Padova since 2011 and Chief of the Hepatobiliary and Liver Transplantation Unit, at the University of Padova Hospital since 2004 (“General Surgery 2 and Liver Transplant Center” since 2019) .
  2. Head of the Department of Surgical, Oncologic and Gastroenterologic Sciences of Padova University (DISCOG) (2023-2027)
  3. Head, Hepatology Department – Padova University Hospital (2020 - present time)
  4. President of the Italian Society of Organ Transplantation (SITO) (2017-2019)
  5. Secretary of the European Society for Organ Transplantation, ESOT (2021-2025)
  6. Member of ESOT Council (European Society for Organ Transplantation). (2017 - 2021)
  7. Co-chair of the ESOT 2021 Congress.
  8. President Elect of ESOT 2025-2027
  9. Member of the Italian Ministry of Health Commission for National Clinical Practice Guidelines (2024)
  10. Italian representative at the European Board of Surgery, section of Transplantation UEMS (European Union of Medical Specialists (2010-present time). Member of the Executive Board of the Transplant Division (Senior Secretary) (2022-present time).
  11. Director of the Italian School for Minimally Invasive Liver Surgery (I-GO-MILS) 2019-2021


  1. Since 2012 on, he led the national consensus process leading to the allocation system for liver transplantation in Italy.


  1. 2024: Coordinator of CERTEV (Veneto Region Center for Translational Research on Hepatobiliary Tumors)


  1. Prof Cillo is first author or co-author of 526 reviewed publications, 28 chapters and 5 monographs. I.F. (JCR) 1372,892 H-INDEX 64 (Scopus) 70 (Google Scholar) Citations: 17834 (Scopus) 22096 (Google Scholar), mainly dedicated to oncologic hepato-biliary surgery, transplant oncology, immunosuppression.
  2. Prof Cillo has performed as first surgeon/tutor over 4000 interventions of general and hepatobiliary surgery, over 900 liver transplants, more than 120 cases of paediatric liver transplantation including split child-adult and adult-adult, living donors and robotic living donations.
  3. He performed the first auxiliary liver transplantation (2007), the first liver auto-transplantation (2011), the first “RAPID” technique (2018) and the first “dual Liver Transplantation” (2023) in Italy. He published the first series of the West of full Robotic resection and reconstruction for pCCA (2021).
  4. Since 2004 more than 2600 liver resections, 2000 liver transplants and 3900 liver ablations have been performed at his Unit.
  5. His scientific interest is focused on the following topics:
  6. Hepatocellular Carcinoma and Primary Liver Tumors
  7. Transplant Oncology
  8. Long term ex situ Machine Perfusion Preservation
  9. Immunosuppression
  10. Organ Allocation








  1. Impact indices (computed on displayed results only)
NormalizationCitationsh-indexg-indexe-indexdelta-hdelta-g
none22096.0070.00134.0097.001.00127.00
per co-authorship6069.1035.0062.0044.004.0029.50
per age2251.8020.0029.0017.002.405.70









Umberto Cillo November 2024




Organizations

Career arc: 1994 - 2026

Source: PubMed

Azienda Ospedaliera di Padova

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 996

Citations

Citations: 21 299 1st author: 73 Last author: 196 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Targeted Peri-operative Prophylaxis in Patients Colonized With Carbapenem Resistant Enterobacterales Undergoing Liver Transplantation: A Multinational Cohort Study.
PMID 41875928 — liver transplantation, pharmaceutical preparations, cohort studies, liver, transplants, communicable diseases, carbapenems, transplantation, infections
Clin Infect Dis20260
Reply: Who should receive a graft for unresectable colorectal liver metastases? Lessons from real-world TransMet validation for living-donor programs.
PMID 42950236 — liver transplantation, liver, neoplasm metastasis, transplants
Liver Transpl20260
Multicentre parallel-group open-label non-inferiority randomized clinical trial of recooling versus no recooling after normothermic machine perfusion in liver transplantation: ARANMP-LT protocol.
PMID 42862941 — liver transplantation, surgical procedures, operative, liver, transplantation
BJS Open20260
The projected rise of pancreatic cancer mortality in Italy: forecasts until 2035.
PMID 42837076 — pancreatic neoplasms, mortality, islands, neoplasms, sex, general surgery
Updates Surg20260
Predictors of morbidity and oncological benefit after liver resection with vascular reconstruction: international collaborative study from expert centres.
PMID 42803787 — mortality, carcinoma, hepatocellular, hepatic veins, portal vein, liver, vena cava, inferior, operative time, transplants, morbidity, veins, cholangiocarcinoma, extrahepatic cholangiocarcinoma
BJS Open20260

Clinical Studies 26

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 11 Study Chair: 4 Study Director: 1

By phase:

N/A 16
Phase 2 6
Phase 3 3
Phase 4 1

By status:

Completed 11
Recruiting 8
Unknown 6
Active not recruiting 1

By type:

Interventional 17
Observational 9

By Monocentric/Multicentric:

monocentric 17
multicentric2to4 2
multicentric5to9 1
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 9

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
NCT07692490 — liver transplantation, organ preservation, cold temperature, liver, solutions, reperfusion, reperfusion injury, transplants, ischemia, allografts, transplantation, temperature
N/ARecruiting2026
Robotically Assisted Surgery For Perihilar Cholangiocarcinoma A Prospective Study
NCT06720883 — lymph node excision, klatskin tumor, neoplasms, liver, hepatectomy, robotic surgical procedures, prospective studies, cholangiocarcinoma, extrahepatic cholangiocarcinoma
N/ARecruiting2024
HOPE Against Cancer Recurrence in HCC
NCT06717919 — liver transplantation, carcinoma, hepatocellular, cold temperature, neoplasms, portal vein, hepatic artery, arteries, liver, solutions, hepatectomy, transplants, histidine, veins, transplantation, universities, temperature, carcinoma
Phase 4Recruiting2025
Conversion Surgery Vs Palliative Care in Pancreatic Cancer Oligometastatic to the Liver
NCT06690528 — radiotherapy, pancreatic neoplasms, neoplasms, multiple chronic conditions, drug therapy, liver, neoplasm metastasis, therapeutics, palliative care, wounds and injuries, needles, chemotherapy
Phase 2Recruiting2024
Selection Protocol for Liver Transplantation in Patients Aged Over 70 Years
NCT06382740 — liver diseases, liver transplantation, end stage liver disease, liver, algorithms, aged, transplants, transplantation
N/ARecruiting2022

LeadR Networks

Main global connection map